Martin Edwards

Insider Reports History

Location
Burlington, MA
Signature
/s/ Andrew Fisher, Attorney-in-fact for Martin Edwards
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Martin Edwards:

Company Role Class Num Shares Value Price $ Report Date Ownership
Morphic Holding, Inc. Director Common Stock 0 $0 $55.79 16 Aug 2024 Direct
Verona Pharma plc Director Ordinary Shares 0 $0 $106.71 07 Oct 2025 Direct
Verona Pharma plc Director Restricted Share Units 96,000 25 Apr 2025 Direct
Verona Pharma plc Director Restricted Stock Units 72,000 01 Aug 2025 Direct
Inozyme Pharma, Inc. Director Stock Option (right to buy) 28,000 18 Jun 2024 Direct
KalVista Pharmaceuticals, Inc. Director Director Stock Option (Right to Buy) 10,000 30 Sep 2021 Direct
Morphic Holding, Inc. Director Stock Option (Right to Buy) 0 16 Aug 2024 Direct
REATA PHARMACEUTICALS INC Director Class A common stock 0 $172.03 26 Sep 2023 Direct
REATA PHARMACEUTICALS INC Director Stock Option (right to buy) 0 26 Sep 2023 Direct
Verona Pharma plc Director Restricted Share Unit 0 07 Oct 2025 Direct
Verona Pharma plc Director Share Options (Right to Buy) 0 07 Oct 2025 Direct

Insider Reports Filed by Martin Edwards

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VRNA Verona Pharma plc 07 Oct 2025 8 $0 4 Director 08 Oct 2025, 16:33
VRNA Verona Pharma plc 01 Aug 2025 3 -$142,057 4 Director 05 Aug 2025, 20:20
VRNA Verona Pharma plc 25 Apr 2025 1 $0 4 Director 29 Apr 2025, 17:15
/report/000141588924021823-edwards-martin-2024-08-16 Morphic Holding, Inc. 16 Aug 2024 6 $0 4 Director 21 Aug 2024, 16:36
INZY Inozyme Pharma, Inc. 18 Jun 2024 1 $0 4 Director 20 Jun 2024, 16:07
/report/000141588924015691-edwards-martin-2024-06-04 Morphic Holding, Inc. 04 Jun 2024 1 $0 4 Director 05 Jun 2024, 20:21
VRNA Verona Pharma plc 29 Apr 2024 1 $0 4 Director 30 Apr 2024, 16:17
VRNA Verona Pharma plc 20 Nov 2023 1 +$61,973 4 Director 22 Nov 2023, 17:09
/report/000120919123055428-edwards-martin-2023-11-13 Morphic Holding, Inc. 13 Nov 2023 1 +$48,803 4 Director 15 Nov 2023, 19:00
/report/000089924323019533-edwards-martin-2023-09-26 REATA PHARMACEUTICALS INC 26 Sep 2023 9 $0 4 Director 26 Sep 2023, 16:30
INZY Inozyme Pharma, Inc. 13 Jun 2023 1 $0 4 Director 15 Jun 2023, 16:05
/report/000120919123035769-edwards-martin-2023-06-07 REATA PHARMACEUTICALS INC 07 Jun 2023 4 +$182,354 4 Director 09 Jun 2023, 16:13
/report/000120919123034627-edwards-martin-2023-06-01 Morphic Holding, Inc. 01 Jun 2023 1 $0 4 Director 05 Jun 2023, 18:59
VRNA Verona Pharma plc 28 Apr 2023 1 $0 4 Director 28 Apr 2023, 16:22
INZY Inozyme Pharma, Inc. 10 Jun 2022 1 $0 4 Director 14 Jun 2022, 07:48
/report/000120919122036113-edwards-martin-2022-06-08 Morphic Holding, Inc. 08 Jun 2022 1 $0 4 Director 10 Jun 2022, 19:00
/report/000120919122035381-edwards-martin-2022-06-08 REATA PHARMACEUTICALS INC 08 Jun 2022 4 +$159,942 4 Director 09 Jun 2022, 16:20
VRNA Verona Pharma plc 28 Apr 2022 1 $0 4 Director 29 Apr 2022, 16:44
/report/000120919122001623-edwards-martin-2022-01-03 REATA PHARMACEUTICALS INC 03 Jan 2022 2 +$3,210 4 Director 05 Jan 2022, 15:02
KALV KalVista Pharmaceuticals, Inc. 30 Sep 2021 1 $0 4 Director 04 Oct 2021, 16:53
VRNA Verona Pharma plc 09 Aug 2021 1 $0 4 Director 10 Aug 2021, 16:46
INZY Inozyme Pharma, Inc. 23 Jun 2021 1 $0 4 Director 24 Jun 2021, 16:17
/report/000120919122026232-edwards-martin-2021-06-16-restatement Morphic Holding, Inc. 16 Jun 2021 1 $0 4/A Director 29 Apr 2022, 16:10
/report/000120919121040223-edwards-martin-2021-06-10 REATA PHARMACEUTICALS INC 10 Jun 2021 1 $0 4 Director 14 Jun 2021, 16:11